John Basmaji (@john_basmaji) 's Twitter Profile
John Basmaji

@john_basmaji

Critical care physician and a scientist in the making. MD, PhD (in the works!) #POCUS

ID: 3764012122

calendar_today24-09-2015 20:59:35

326 Tweet

397 Followers

203 Following

Gordon H. Guyatt (@guyattgh) 's Twitter Profile Photo

Big news for #EBM! Just out in #BMJ, ROBUST-RCT, pristinely developed, innovative, simple, user-friendly instrument for risk of bias assessment in #RCTs far superior to anything before, will become standard outside of Cochrane and in #Cochrane if they let folks use it.

Ross Prager (@ross_prager) 's Twitter Profile Photo

John Basmaji Eduardo R Argaiz and I are running a webinar today April 22nd at 3pm EST on POCUS research. There are still a few spots to register 👇 John is Jedi level with research methods and someone I learn from every day! Come pick his brain.

Gordon H. Guyatt (@guyattgh) 's Twitter Profile Photo

Classic #JAMA paper using #MetaRegression to establish that stopping #RCTs early for benefit on average overestimates treatment effects by 29% and creates spurious estimates of effect up to 38% of the time. #EBM #Medicine pubmed.ncbi.nlm.nih.gov/20332404/

ANDROMEDA-SHOCK (@andromedashock) 's Twitter Profile Photo

ANDROMEDA-PEGASUS started recruitment today in Budapest and Montreal! A big cross-sectional study focused on the RR between pulse pressure and stroke volume in diverse clinical settings and static/dynamic situations. Sum of 37 countries, 4 continents, >200 centers, >2000 pts 💪

Curro Miralles (@curromir) 's Twitter Profile Photo

Can a patient be fluid responsive and venously congested at the same time? Yes — and this changes everything. Our recent study shows how bedside ultrasound can reveal what clinical signs often miss. Let’s break it down: #POCUS #VExUS #CriticalCare 🧵

Ross Prager (@ross_prager) 's Twitter Profile Photo

Excited to announce we have finished recruiting for Andromeda-VEXUS, the largest, multi-center, multi-continent (4 continents!) #POCUS study in the world!! HUGE thanks to our physician partners, collaborators, investigators, and most importantly patients and families. With over

Excited to announce we have finished recruiting for Andromeda-VEXUS, the largest, multi-center, multi-continent (4 continents!) #POCUS study in the world!!

HUGE thanks to our physician partners, collaborators, investigators, and most importantly patients and families.

With over
ANDROMEDA-SHOCK (@andromedashock) 's Twitter Profile Photo

The physiological background of ANDROMEDA-SHOCk-2 and ANDROMEDA-PEGASUS!!!! A2 analysis is almost there but we are pretty optimistic! Opening avenues for personalizing initial hemodynamic management! Cross-fingers

The physiological background of ANDROMEDA-SHOCk-2 and ANDROMEDA-PEGASUS!!!! A2 analysis is almost there but we are pretty optimistic! Opening avenues for personalizing initial hemodynamic management! Cross-fingers
ANDROMEDA-SHOCK (@andromedashock) 's Twitter Profile Photo

Writing ANDROMEDA-SHOCK-2 draft with the great Eduardo Kattan on a cold Holiday morning at the University. Empty Streets. Blues on the background. Pretty excited by the results that we cannot tell yet jajaja. In contact with Jan Bakker, Gustavo Ospina , Alex Cavalcanti💪💪😎🍷

Writing ANDROMEDA-SHOCK-2 draft with the great Eduardo Kattan on a cold Holiday morning at the University. Empty Streets. Blues on the background. Pretty excited by the results that we cannot tell yet jajaja. In contact with Jan Bakker, Gustavo Ospina , Alex Cavalcanti💪💪😎🍷
Vimal Bhardwaj (@drvimalzenicu) 's Twitter Profile Photo

🎯 *Endotracheal tube blocks can be unpredictable. Our publication in CHEST Critical Care 2025** 🔬 *Mapping the Epidemiologic Features of Endotracheal Tube Obstruction* 🔗 chestcc.org/article/S2949-… #CriticalCare #ETTblock #PatientSafety #CHESTCriticalCare

🎯 *Endotracheal tube blocks can be unpredictable. Our publication in CHEST Critical Care 2025**

🔬 *Mapping the Epidemiologic Features of Endotracheal Tube Obstruction*    
🔗 chestcc.org/article/S2949-…

#CriticalCare  #ETTblock #PatientSafety #CHESTCriticalCare
Ross Prager (@ross_prager) 's Twitter Profile Photo

(1/X) People are increasingly talking about multimodal diuresis, but what will it actually do for your patients if done right? A 🧵

(1/X) People are increasingly talking about multimodal diuresis, but what will it actually do for your patients if done right?

A 🧵
ANDROMEDA-SHOCK (@andromedashock) 's Twitter Profile Photo

More Info Coming soon! Sixth version of our International Hemodynamic Monitoring and Tissue Perfusion Course (bilingual and online). In the meantime Save the date! To get immediate details mail to Gabriela Wachholtz ([email protected])

More Info Coming soon! Sixth version of our International Hemodynamic Monitoring and Tissue Perfusion Course (bilingual and online). In the meantime Save the date! To get immediate details mail to Gabriela Wachholtz (gabriela.wachholtz@uc.cl)
ANDROMEDA-SHOCK (@andromedashock) 's Twitter Profile Photo

Highlights of our upcoming VI international online Hemodynamic Monitoring And Tissue Perfusion Course! The second day, not to be missed!

Highlights of our upcoming VI international online Hemodynamic Monitoring And Tissue Perfusion Course! The second day, not to be missed!
Ross Prager (@ross_prager) 's Twitter Profile Photo

Our critical care ultrasound fellows and staff CriticalCareWestern enjoying journal club, dinner, and TEE images on a rooftop jumbotron. POCUS doesn't get better than this!

Our critical care ultrasound fellows and staff <a href="/CritCareWestern/">CriticalCareWestern</a>  enjoying journal club, dinner, and TEE images on a rooftop jumbotron. 

POCUS doesn't get better than this!